Role of cardiovascular biomarkers for the assessment of mitral stenosis and its complications

Badoz M., Arrigob M., Iung B., Amioglu G., YILMAZ M. B., Meneveau N., ...More

EUROPEAN JOURNAL OF INTERNAL MEDICINE, vol.34, pp.58-62, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 34
  • Publication Date: 2016
  • Doi Number: 10.1016/j.ejim.2016.05.008
  • Journal Name: EUROPEAN JOURNAL OF INTERNAL MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.58-62
  • Keywords: Mitral stenosis, Pulmonary hypertension, Biomarker, BNP, MR-proANP, sCD146, NATRIURETIC PEPTIDE, B-TYPE, HEART-FAILURE, ECHOCARDIOGRAPHIC-ASSESSMENT, LEVELS CORRELATE, ATRIAL, RECOMMENDATIONS, SEVERITY, SYMPTOMS, PROBNP
  • Dokuz Eylül University Affiliated: No

Abstract

Background: Mitral stenosis (MS) may cause progressive dyspnea on exertion, pulmonary hypertension (PH), atrial fibrillation and right ventricular (RV) failure. Patients with MS presenting with change in dyspnea severity often require a complete cardiologic assessment, but the use of biomarkers may be an alternative for the initial assessment of MS and its complications. The aim of this study was to evaluate the role of several cardiovascular biomarkers for this purpose.